Zbigniew Konopski
- Consultant
Publications 2022
[Transjugular intrahepatic portosystemic shunt for portal hypertension]
Tidsskr Nor Laegeforen, 142 (14)
DOI 10.4045/tidsskr.21.0911, PubMed 36226423
Publications 2021
Successful Control of Hepatitis B Virus Reactivation following Restart of Ibrutinib in Chronic Lymphocytic Leukaemia
Case Rep Hematol, 2021, 1862446
DOI 10.1155/2021/1862446, PubMed 34721911
Publications 2020
Effect of gender on mortality and causes of death in cirrhotic patients with gastroesophageal varices. A retrospective study in Norway
PLoS One, 15 (3), e0230263
DOI 10.1371/journal.pone.0230263, PubMed 32163489
Publications 2016
Hepatitis C reinfection after sustained virological response
J Hepatol, 64 (5), 1020-1026
DOI 10.1016/j.jhep.2016.01.001, PubMed 26780289
Publications 2015
Randomised controlled trial of temoporfin photodynamic therapy plus chemotherapy in nonresectable biliary carcinoma--PCS Nordic study
Photodiagnosis Photodyn Ther, 13, 330-333
DOI 10.1016/j.pdpdt.2015.09.004, PubMed 26415549
Increased Serum Levels of LIGHT/TNFSF14 in Nonalcoholic Fatty Liver Disease: Possible Role in Hepatic Inflammation
Clin Transl Gastroenterol, 6 (7), e95
DOI 10.1038/ctg.2015.23, PubMed 26133108
Publications 2012
Combining transient elastography with FIB4 enhances sensitivity in detecting advanced fibrosis of the liver
Scand J Gastroenterol, 48 (1), 93-100
DOI 10.3109/00365521.2012.746389, PubMed 23205894
Publications 2011
Low liver stiffness among cirrhotic patients with hepatitis B after prolonged treatment with nucleoside analogs
Scand J Gastroenterol, 46 (6), 760-6
DOI 10.3109/00365521.2011.565068, PubMed 21438780
A rapid chemokine response of macrophage inflammatory protein (MIP)-1α, MIP-1β and the regulated on activation, normal T expressed and secreted chemokine is associated with a sustained virological response in the treatment of chronic hepatitis C
Clin Microbiol Infect, 17 (2), 204-9
DOI 10.1111/j.1469-0691.2010.03206.x, PubMed 20219081
Fetuin A in nonalcoholic fatty liver disease: in vivo and in vitro studies
Eur J Endocrinol, 166 (3), 503-10
DOI 10.1530/EJE-11-0864, PubMed 22170794
Publications 2010
Intracellular nicotinamide phosphoribosyltransferase protects against hepatocyte apoptosis and is down-regulated in nonalcoholic fatty liver disease
J Clin Endocrinol Metab, 95 (6), 3039-47
DOI 10.1210/jc.2009-2148, PubMed 20392873
Publications 2009
Metformin in patients with non-alcoholic fatty liver disease: a randomized, controlled trial
Scand J Gastroenterol, 44 (7), 853-60
DOI 10.1080/00365520902845268, PubMed 19811343
A complex role of activin A in non-alcoholic fatty liver disease
Am J Gastroenterol, 104 (9), 2196-205
DOI 10.1038/ajg.2009.318, PubMed 19532130
Publications 2008
ASAT/ALAT ratio provides prognostic information independently of Child-Pugh class, gender and age in non-alcoholic cirrhosis
Scand J Gastroenterol, 43 (10), 1241-8
DOI 10.1080/00365520802158614, PubMed 18609128
Publications 2007
Incidence rates and causes of cirrhosis in a Norwegian population
Scand J Gastroenterol, 42 (12), 1501-8
DOI 10.1080/00365520701478014, PubMed 17852839
Occurrence of hepatoxicicty and elevated liver enzymes in a Crohn's disease patient treated with infliximab
Inflamm Bowel Dis, 13 (12), 1584-6
DOI 10.1002/ibd.20230, PubMed 17663423
Publications 2006
Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2
J Hepatol, 44 (6), 1167-74
DOI 10.1016/j.jhep.2006.02.011, PubMed 16618517
Publications 2005
Abnormal glucose tolerance is a predictor of steatohepatitis and fibrosis in patients with non-alcoholic fatty liver disease
Scand J Gastroenterol, 40 (12), 1469-77
DOI 10.1080/00365520500264953, PubMed 16293559
Publications 2001
[Non-alcoholic steatohepatitis]
Tidsskr Nor Laegeforen, 121 (20), 2377-80
PubMed 11603045
Ikke-alkoholisk steatohepatitt
In Tidsskrift for Den norske legeforening, Foreningen, Oslo, 121(2001)nr. 20, S. 2377-2380
BIBSYS 022000674
Publications 1995
In vitro studies on the uptake of ?-1,3-D-glucan by macrophages
Institute of Medical Biology, University of Tromsø, Tromsø, 1 b. (flere pag.)
BIBSYS 950705063, ISBN 82-7589-043-8
Interferon-gamma inhibits endocytosis of soluble animated beta-1,3-D-glucan and neutral red in mouse peritoneal macrophages
J Interferon Cytokine Res, 15 (7), 597-603
DOI 10.1089/jir.1995.15.597, PubMed 7553229
Publications 1994
The effects of plasma and albumin infusion on organ function and sepsis markers in experimental gram-negative sepsis
Shock, 2 (6), 402-7
DOI 10.1097/00024382-199412000-00003, PubMed 7743369
IFN-gamma inhibits internalization of soluble aminated beta-1,3-D-glucan by macrophages and thereby down-regulates the glucan induced release of TNF-alpha and IL-1 beta
Scand J Immunol, 40 (1), 57-63
DOI 10.1111/j.1365-3083.1994.tb03433.x, PubMed 8029644
A novel immunomodulator soluble aminated beta-1,3-D-glucan: binding characteristics to mouse peritoneal macrophages
Biochim Biophys Acta, 1221 (1), 61-5
DOI 10.1016/0167-4889(94)90216-x, PubMed 8130277
The TNF Receptors p55 and p75 Mediate Chemotaxis of PMN Induced by TNFalpha and a TNFalpha 36-62 Peptide
Mediators Inflamm, 3 (5), 347-52
DOI 10.1155/S0962935194000487, PubMed 18475579
Publications 1993
Cytokines and PGE2 modulate the phagocytic function of the beta-glucan receptor in macrophages
Scand J Immunol, 37 (5), 587-92
DOI 10.1111/j.1365-3083.1993.tb02576.x, PubMed 8387227
Publications 1992
Killing of Escherichia coli by mononuclear phagocytes and neutrophils stimulated in vitro with beta-1,3-D-polyglucose derivatives
Microbiol Immunol, 36 (11), 1173-88
DOI 10.1111/j.1348-0421.1992.tb02120.x, PubMed 1491620
Publications 1991
Phagocytosis of beta-1,3-D-glucan-derivatized microbeads by mouse peritoneal macrophages involves three different receptors
Scand J Immunol, 33 (3), 297-306
DOI 10.1111/j.1365-3083.1991.tb01775.x, PubMed 1849314
Publications 1990
Noen vanlige sykdomsmekanismer: innføring i generell patologi til Organkurs I, "Introduksjon Biomedisin"
[Universitetet], Tromsø, 72, VIII s.
BIBSYS 941158705